{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:21:12Z","timestamp":1790979672275,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:00:00Z","timestamp":1314921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s13277-011-0226-x","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T19:23:14Z","timestamp":1314904994000},"page":"1225-1231","source":"Crossref","is-referenced-by-count":25,"title":["SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer"],"prefix":"10.1007","volume":"32","author":[{"given":"Hong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Widegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,2]]},"reference":[{"key":"226_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225\u201349.","journal-title":"CA Cancer J Clin"},{"key":"226_CR2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/PPO.0b013e3181e07606","volume":"16","author":"R Midgley","year":"2010","unstructured":"Midgley R, Rasul K, Al Salama H, Kerr DJ. Gene profiling in early stage disease. Cancer J. 2010;16:210\u20133.","journal-title":"Cancer J"},{"key":"226_CR3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI12609","volume":"107","author":"JE Murphy-Ullrich","year":"2001","unstructured":"Murphy-Ullrich JE. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest. 2001;107:785\u201390.","journal-title":"J Clin Invest"},{"key":"226_CR4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1357-2725(99)00090-4","volume":"31","author":"M Kouros","year":"1999","unstructured":"Kouros M. SPARC (osteonectin\/BM-40). Int J Biochem Cell Biol. 1999;31:1363\u20136.","journal-title":"Int J Biochem Cell Biol"},{"key":"226_CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1369\/jhc.3A6245.2004","volume":"52","author":"RA Brekken","year":"2004","unstructured":"Brekken RA, Sullivan MM, Workman G, et al. Expression and characterization of murine Hevin (SC1), a member of the SPARC family of matricellular proteins. J Histochem Cytochem. 2004;52:735\u201348.","journal-title":"J Histochem Cytochem"},{"key":"226_CR6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.biocel.2004.01.017","volume":"36","author":"MM Sullivan","year":"2004","unstructured":"Sullivan MM, Sage EH. Hevin\/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC\/BM-40\/Osteonectin family. Int J Biochem Cell Biol. 2004;36:991\u20136.","journal-title":"Int J Biochem Cell Biol"},{"key":"226_CR7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jcb.20091","volume":"92","author":"PE Framson","year":"2004","unstructured":"Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? J Cell Biochem. 2004;92:679\u201390.","journal-title":"J Cell Biochem"},{"key":"226_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drup.2008.08.005","volume":"11","author":"IT Tai","year":"2008","unstructured":"Tai IT, Tang MJ. SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updates. 2008;11:231\u201346.","journal-title":"Drug Resist Updates"},{"key":"226_CR9","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-04-2463","volume":"65","author":"MB Mintz","year":"2005","unstructured":"Mintz MB, Sowers R, Brown KM, et al. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Res. 2005;65:1748\u201354.","journal-title":"Cancer Res"},{"key":"226_CR10","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1074\/jbc.M212291200","volume":"278","author":"HO Hambrock","year":"2003","unstructured":"Hambrock HO, Nitsche P, Hansen U, et al. SC1\/Hevin: an extracellular calcium-modulated protein that binds collagen. J Biol Chem. 2003;278:11351\u20138.","journal-title":"J Biol Chem"},{"key":"226_CR11","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1074\/jbc.271.8.4511","volume":"271","author":"JP Girard","year":"1996","unstructured":"Girard JP, Springer TA. Modulation of endothelial cell adhesion by Hevin, an acidic protein associated with high endothelial venules. J Biol Chem. 1996;271:4511\u20137.","journal-title":"J Biol Chem"},{"key":"226_CR12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1054\/bjoc.1999.1051","volume":"82","author":"A Claeskens","year":"2000","unstructured":"Claeskens A, Ongenae N, Neefs JM, et al. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br J Cancer. 2000;82:1123\u201330.","journal-title":"Br J Cancer"},{"key":"226_CR13","first-page":"232","volume":"58","author":"PS Nelson","year":"1998","unstructured":"Nelson PS, Plymate SR, Wang K, et al. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res. 1998;58:232\u20136.","journal-title":"Cancer Res"},{"key":"226_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1593\/neo.06646","volume":"9","author":"I Esposito","year":"2007","unstructured":"Esposito I, Kayed H, Keleg S, et al. Tumor-suppressor function of SPARC-like protein 1\/Hevin in pancreatic cancer. Neoplasia. 2007;9:8\u201317.","journal-title":"Neoplasia"},{"key":"226_CR15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjc.6603346","volume":"95","author":"S Biade","year":"2006","unstructured":"Biade S, Marinucci M, Schick J, et al. Gene expression profiling of human ovarian tumours. Br J Cancer. 2006;95:1092\u2013100.","journal-title":"Br J Cancer"},{"key":"226_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.2278","volume":"214","author":"A Bergamaschi","year":"2008","unstructured":"Bergamaschi A, Tagliabue E, S\u00f8rlie T, et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol. 2008;214:357\u201367.","journal-title":"J Pathol"},{"key":"226_CR17","first-page":"521","volume":"18","author":"SG Isler","year":"2001","unstructured":"Isler SG, Schenk S, Bendik I, et al. Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers. Int J Oncol. 2001;18:521\u20136.","journal-title":"Int J Oncol"},{"key":"226_CR18","first-page":"626","volume":"58","author":"I Bendik","year":"1998","unstructured":"Bendik I, Schraml P, Ludwig CU. Characterization of MAST9\/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer. Cancer Res. 1998;58:626\u20139.","journal-title":"Cancer Res"},{"key":"226_CR19","first-page":"1073","volume":"25","author":"SG Isler","year":"2004","unstructured":"Isler SG, Ludwig CU, Chiquet-Ehrismann R, Schenk S. Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors. Int J Oncol. 2004;25:1073\u20139.","journal-title":"Int J Oncol"},{"key":"226_CR20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/path.2068","volume":"210","author":"CPY Lau","year":"2006","unstructured":"Lau CPY, Poon RTP, Cheung ST, Yu WC, Fan ST. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol. 2006;210:459\u201368.","journal-title":"J Pathol"},{"key":"226_CR21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/BF02258221","volume":"41","author":"A Oberg","year":"1998","unstructured":"Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes stages A and B colorectal cancer? Dis Colon Rectum. 1998;41:1244\u20139.","journal-title":"Dis Colon Rectum"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-011-0226-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-011-0226-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-011-0226-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:24:36Z","timestamp":1559489076000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-011-0226-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,2]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1007\/s13277-011-0226-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,2]]}}}